AU2001280911A1 - Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10 - Google Patents
Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10Info
- Publication number
- AU2001280911A1 AU2001280911A1 AU2001280911A AU8091101A AU2001280911A1 AU 2001280911 A1 AU2001280911 A1 AU 2001280911A1 AU 2001280911 A AU2001280911 A AU 2001280911A AU 8091101 A AU8091101 A AU 8091101A AU 2001280911 A1 AU2001280911 A1 AU 2001280911A1
- Authority
- AU
- Australia
- Prior art keywords
- encoded
- cytomegalovirus encoded
- rhesus
- immunologic activities
- cytomegalovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000701024 Human betaherpesvirus 5 Species 0.000 title 1
- 241000218605 Macacine betaherpesvirus 3 Species 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22183100P | 2000-07-28 | 2000-07-28 | |
| US60221831 | 2000-07-28 | ||
| PCT/US2001/023942 WO2002032457A1 (fr) | 2000-07-28 | 2001-07-30 | Activites immunologiques du cytomegalovirus de rhesus code il-10 et du cytomegalovirus humain code il-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001280911A1 true AU2001280911A1 (en) | 2002-04-29 |
Family
ID=22829580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001280911A Abandoned AU2001280911A1 (en) | 2000-07-28 | 2001-07-30 | Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20020197234A1 (fr) |
| EP (1) | EP1307228A4 (fr) |
| AU (1) | AU2001280911A1 (fr) |
| WO (1) | WO2002032457A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050281885A1 (en) * | 2004-06-21 | 2005-12-22 | Egilmez Nejat K | Method for treating inflammatory bowel disease by oral administration of IL-10 |
| EP4582440A3 (fr) * | 2018-12-21 | 2025-10-08 | The Regents of the University of California | Vaccins contenant il-10 et leurs utilisations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827513A (en) * | 1990-06-29 | 1998-10-27 | Schering Corporation | Methods of treating insulin-dependent diabetes mellitus by administration of IL-10 |
| US5833976A (en) * | 1991-08-06 | 1998-11-10 | Schering Corporation | Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity |
| US5368854A (en) * | 1992-08-20 | 1994-11-29 | Schering Corporation | Use of IL-10 to treat inflammatory bowel disease |
| US5601815A (en) * | 1992-08-21 | 1997-02-11 | Schering Corp | IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells |
| TW381026B (en) * | 1993-01-13 | 2000-02-01 | Schering Corp | Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells |
| US5866134A (en) * | 1995-03-24 | 1999-02-02 | Schering Corporation | Method for enhancing the antibody response to specific antigens with Interleukin-10 |
| US5770190A (en) * | 1995-07-14 | 1998-06-23 | Schering Corporation | Method of treatment of acute leukemia with inteleukin-10 |
| US6022536A (en) * | 1995-08-09 | 2000-02-08 | Schering Corporation | Combined use of interleukin 10 and cyclosporin for immunosuppression therapy |
| AU7346100A (en) * | 1999-09-02 | 2001-03-26 | University Of Medicine And Dentistry Of New Jersey | Cytomegalovirus-encoded il-10 homolog |
-
2001
- 2001-07-30 AU AU2001280911A patent/AU2001280911A1/en not_active Abandoned
- 2001-07-30 WO PCT/US2001/023942 patent/WO2002032457A1/fr not_active Ceased
- 2001-07-30 EP EP01959344A patent/EP1307228A4/fr not_active Withdrawn
- 2001-07-30 US US09/919,224 patent/US20020197234A1/en not_active Abandoned
-
2005
- 2005-02-10 US US11/057,104 patent/US20050191274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050191274A1 (en) | 2005-09-01 |
| EP1307228A1 (fr) | 2003-05-07 |
| WO2002032457A1 (fr) | 2002-04-25 |
| EP1307228A4 (fr) | 2005-05-18 |
| US20020197234A1 (en) | 2002-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002323210A1 (en) | Bio-synthetic photostimulators and methods of use | |
| AU2001286171A1 (en) | Human cDNAs and proteins and uses thereof | |
| AU2002306768A1 (en) | Expression profiles and methods of use | |
| AU2002314466A1 (en) | Withasol and methods of use | |
| AU2001227751A1 (en) | Thermal joint and method of use | |
| AU2003288902A1 (en) | Microcapsules and methods of use | |
| AU2003226152A1 (en) | Multifunctional flavor systems and method of use | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU2002335085A1 (en) | Angiopoietins and methods of use thereof | |
| AU2002359512A1 (en) | Belts and methods of use thereof | |
| AU2002213355A1 (en) | Wireless asp systems and methods | |
| AUPR301001A0 (en) | Compression garments and methods of use | |
| AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
| AU2002338655A1 (en) | Methods of preparing sulfinamide and sulfoxides | |
| AU2003245487A1 (en) | Cosmetic appliance and method of use | |
| AU2001261375A1 (en) | Human caspase-12 materials and methods | |
| AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
| AU2001249567A1 (en) | Shaped springs and methods of fabricating and using shaped springs | |
| AU2002310237A1 (en) | Sponge-derived terpenoids and methods of use | |
| AU2001280911A1 (en) | Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10 | |
| AU2001264863A1 (en) | Preparation of fagopyritols and uses therefor | |
| AU2001233588A1 (en) | New toralactone and its derivation and the use of decreasing blood-fat and losing weight | |
| AU2002222125A1 (en) | Prevention and treatment of tachyphylactic response | |
| AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
| AU2003274919A1 (en) | Multifunctional context-activated protides and methods of use |